Anxiety disorders - Articles | CARLAT PUBLISHING

EXPERT Q&A

Philosophy of Psychiatry: Key Essentials for Therapists

April 17, 2024

Awais Aftab, MD. Psychiatrist in Cleveland, Ohio, and Clinical Assistant Professor of Psychiatry at Case Western Reserve University. He writes an online newsletter, Psychiatry at the Margins. Twitter: @awaisaftab

Dr. Aftab has no financial relationships with companies related to this material.

Although psychiatry and philosophy are largely theoretical disciplines, they have relevance in the everyday work of psychiatrists and psychotherapists.

CLINICAL UPDATE

CBT With Exposure and Response Prevention for OCD

December 5, 2023

Daniel Carlat, MD

Daniel Carlat, MD. Vice Chair, Community and Public Sector Psychiatry, Tufts University School of Medicine. Publisher, Carlat Publishing.

Dr. Carlat has no financial relationships with companies related to this material.

Seven steps to implementing exposure and response prevention techniques.

Research Update

Mirtazapine Augmentation in OCD

November 9, 2023

Kate J. Travis, MD

Kate J. Travis, MD. Dr. Travis has no financial relationships with companies related to this material.

In theory, mirtazapine may worsen OCD, or it may help. This first-of-its-kind trial puts it to the randomized test.

Expert Q&A

Treating OCD With Co-Occurring Conditions

November 1, 2023

Kate Dimond Fitzgerald, MD

Kate Dimond Fitzgerald, MD.

Child and adolescent psychiatrist; Ruane Professor of Child and Adolescent Psychiatry, Department of Psychiatry, Columbia University; New York State Psychiatric Institute, New York, NY.

Dr. Fitzgerald has no financial relationships with companies related to this material.

In this issue we offer the information you need to treat OCD when it is mixed with other diagnoses.

Expert Q&A

Deprescribing Benzos: A How-To Guide

October 31, 2023

Audrey Abelleira, PharmD, BCPP

Audrey Abelleira, PharmD, BCPP. Clinical pharmacist practitioner, VA Connecticut Healthcare System; clinical instructor, Yale School of Medicine, New Haven, CT.

Dr. Abelleira has no financial relationships with companies related to this material.

Benzodiazepines are widely prescribed but carry significant risks. The best course of action for many patients is to have their benzodiazepine prescription discontinued, but physiologic dependence can make stopping benzodiazepines a big challenge. Dr. Abeillera teaches us how to identify those who might benefit from a taper and covers all the details on how to do it as safely and effectively as possible.

History of Psychiatry

October 30, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

Historian Edward Shorter takes us on a 200 year journey from the age of spa treatments to the birth of psychopharmacology.

Research Update

Which SSRI Is Best for Panic Disorder?

August 7, 2023

Rushaniya Khairova, MD, PhD.

Rushaniya Khairova, MD, PhD. Dr. Khairova has no financial relationships with companies related to this material.

Two SSRIs emerge as top choices for panic disorder in this network meta-analysis.

Research Update

Can Abstaining From Social Media Help People Feel Better?

April 14, 2023

Michael Posternak, MD.

Michael Posternak, MD. Dr. Posternak has no financial relationships with companies related to this material.

What happens when 154 volunteers are randomized to stay off the screen for a week?

Clinical Update

Gabapentin: A Double-Edged Sword

April 1, 2023

Noah Capurso, MD and Shram Shukla, MD

Shram Shukla, MD. Addiction psychiatry fellow, Yale School of Medicine. New Haven, CT.

Noah Capurso, MD, MHS. Assistant professor of psychiatry, Yale University. New Haven, CT. Editor-in-chief of The Carlat Addiction Treatment Report.

Dr. Shukla and Dr. Capurso have no financial relationships with companies related to this material.

Gabapentin has become one of the most widely prescribed medications in America. At the same time, concerns have emerged about its association with opioid overdose deaths. In this article, we review the data behind gabapentin treatment: when it should be used, how to use it, and when it should be avoided.

Clinical Update

Deep Rivers Run Quiet. An Update on Social Anxiety Disorder

March 8, 2023

Steven Hamilton, PhD, MD

Steven Hamilton, MD, PhD. The Permanente Medical Group, Department of Psychiatry, Kaiser Permanente San Francisco Medical Center. Dr. Hamilton has no financial relationships with companies related to this material.

SSRIs and CBT treat social anxiety disorder, but what do you do when they don’t work? Steven Hamilton describes 5 other pharmacotherapy options and shows us how to distinguish social anxiety from normal shyness.